相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life
T. Nguyen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Hidradenitis suppurativa is associated with acne keloidalis nuchae: a population-based study
Khalaf Kridin et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2021)
Burden of Ocular Comorbidities in Patients With Hidradenitis Suppurativa
Rosalynn R. Z. Conic et al.
JAMA DERMATOLOGY (2021)
Adalimumab Dose Intensification in Recalcitrant Hidradenitis Suppurativa/Acne Inversa
Christos C. Zouboulis et al.
DERMATOLOGY (2020)
Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice
Errol P. Prens et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2020)
Low Prevalence of GSC Gene Mutations in a Large Cohort of Predominantly Caucasian Patients with Hidradenitis Suppurativa
Sabine Duchatelet et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice
Lauren A. Orenstein et al.
DERMATOLOGY (2020)
Body size and composition, physical activity and sedentary time in relation to endogenous hormones in premenopausal and postmenopausal women: Findings from the UK Biobank
Sandar Tin Tin et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Evaluation of Cardiovascular Risk in Hidradenitis Suppurativa Patients Using Heart Rate Variability (HRV) Analysis
Nevena Skroza et al.
CARDIOVASCULAR THERAPEUTICS (2020)
Clinical selection criteria in new clinical trials of hidradenitis suppurativa: External validity and implications on the daily clinical practice
Trinidad Montero-Vilchez et al.
DERMATOLOGIC THERAPY (2020)
Frailty status and cardiovascular disease risk profile in middle-aged and older females
Kevin F. Boreskie et al.
EXPERIMENTAL GERONTOLOGY (2020)
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part I: Diagnosis, evaluation, and the use of complementary and procedural management
Ali Alikhan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data
Georgios Nikolakis et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2019)
Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group
Isabel Greco Tavora et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2019)
Update on the contraceptive contraindications
D. Serfaty
JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION (2019)
Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis
Giovanni Damiani et al.
WORLD JOURNAL OF HEPATOLOGY (2019)
Clinical Characteristics of Pruritus and Pain in Patients with Hidradenitis Suppurativa
Lukasz Matusiak et al.
ACTA DERMATO-VENEREOLOGICA (2018)
Acne and hidradenitis suppurativa
A. Pink et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
Patient-centered Contraceptive Counseling and Prescribing
Katherine Rivlin et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2018)
Autoinflammatory Disease Damage Index (ADDI): a possible newborn also in hidradenitis suppurativa daily practice
Giovanni Damiani et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
A unique pneumopathy in a patient with skin nodules and abscesses
Giovanni Damiani et al.
INTERNAL AND EMERGENCY MEDICINE (2017)
Menses and pregnancy affect symptoms in hidradenitis suppurativa: A cross-sectional study
Allard R. J. V. Vossen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Antiandrogenic and antimineralocorticoid health benefits of COC containing newer progestogens: dienogest and drospirenone
Pedro-Antonio Regidor et al.
ONCOTARGET (2017)
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity
C. C. Zouboulis et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment
Maddalena Napolitano et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2017)
HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study
A. B. Kimball et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
Ioannis Karagiannidis et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2016)
Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa
Wayne Gulliver et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2016)
Hidradenitis suppurativa: A comprehensive review
Ali Alikhan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies
Jean E. Revuz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Hidradenitis Suppurativa in 64 female patients: Retrospective study comparing oral antibiotics and antiandrogen therapy
John N. Kraft et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2007)
The natural history of hidradenitis suppurativa
JM von der Werth et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2000)